Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors

Phase 4

Recruiting

Conditions: Survivorship

Interventions: Other: Music Therapy
Other: Cognitive Behavioral Therapy
Other: assessments

First Posted Date: 2022-01-31

Last Posted Date: 2024-07-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 330

Registration Number: NCT05215353

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Drexel University, Philadelphia, Pennsylvania, United States
🇺🇸
Baptist Alliance MCI, Miami, Florida, United States

A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Other: Neurocognitive Tests
Other: Questionnaires

First Posted Date: 2022-01-26

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 54

Registration Number: NCT05207098

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 4 locations

A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor-positive HER2-negative Breast Cancer

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Olaparib
Drug: Pembrolizumab

First Posted Date: 2022-01-24

Last Posted Date: 2024-01-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 23

Registration Number: NCT05203445

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer Stage
Breast Cancer Stage I
Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III
Breast Cancer Stage IV

Interventions: Drug: Triamcinolone Acetonide
Drug: Oleogel-S10

First Posted Date: 2022-01-13

Last Posted Date: 2024-08-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT05190770

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

and more 1 locations

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Phase 2

Recruiting

Conditions: Glioma

Interventions: Drug: Pembrolizumab
Combination Product: Olaparib and Temozolomide

First Posted Date: 2022-01-12

Last Posted Date: 2024-12-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 57

Registration Number: NCT05188508

Locations: 🇺🇸
BAPTIST ALLIANCE - MCI (Data Collection Only), Miami, Florida, United States
🇺🇸
Hartford Healthcare Alliance (Data Collection Only), Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 7 locations

A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis

Phase 1

Recruiting

Conditions: Leptomeningeal Metastases

Interventions: Drug: Deferoxamine (DFO)

First Posted Date: 2022-01-11

Last Posted Date: 2024-01-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT05184816

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Radiation: Whole liver irradiation (WLI)
Drug: Gemcitabine and Cisplatin

First Posted Date: 2022-01-10

Last Posted Date: 2024-11-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1

Registration Number: NCT05182112

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT)

First Posted Date: 2021-12-27

Last Posted Date: 2024-11-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 215

Registration Number: NCT05169970

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma

Phase 2

Active, not recruiting

Conditions: Endometrial Carcinosarcoma

Interventions: Drug: Pembrolizumab
Drug: Olaparib

First Posted Date: 2021-12-14

Last Posted Date: 2024-05-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT05156268

Locations: 🇺🇸
Maria Rubinstein, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma

Phase 2

Recruiting

Conditions: Uterine Carcinosarcoma
Advanced Uterine Carcinosarcoma

Interventions: Drug: Pembrolizumab
Drug: Lenvatinib

First Posted Date: 2021-12-07

Last Posted Date: 2024-05-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT05147558

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy